ClinicalTrials.gg
CompletedNCT00629694Updated Jan 23, 2012

Adenoidectomy, Myringotomy and Tubes' Insertion vs Adenoidectomy and Myringotomy Alone in Children With Otitis Media With Effusion and Adenoid Hypertrophy

A Phase 2 interventional study of adenoidectomy, myringotomy, tubes insertion and A-M in Otitis Media With Effusion, sponsored by Aghia Sophia Children's Hospital of Athens. Completed at 1 site in Greece. Open to participants aged 3 Years to 12 Years. Per ClinicalTrials.gov, last updated 2012-01-23.

Sponsored by Aghia Sophia Children's Hospital of Athens · Phase 2, Interventional, and Treatment

Phase
Phase 2
Study type
Interventional
Enrollment
52
Allocation
Randomized
Ages
3 Years to 12 Years
Sex
All
01

Study summary

It is not unusual for several children operated for severe adenoid hyperthrophy causing breathing problems to have otitis media with effusion simultaneously. It is unknown whether adenoidectomy, myringotomy and tubes insertion is superior to adenoidectomy and myringotomy alone in terms of otitis media related quality of life and recurrence of otitis media several months after the operation. For this purpose a randomized trial is conducted including children operated for adenoid hyperthrophy and whose otitis media with effusion had caused minimal or no symptoms so far

02

Conditions studied

  • Otitis Media With Effusion

Keywords

  • adenoidectomy, myringotomy, tubes insertion, otitis media, adenoid hyperthophy
03

In context

Otitis Media with Effusion

88 studies on the registry are indexed under Otitis Media with Effusion; 17 are open to participants now.

This study's enrollment of 52 is below the median of 80 across 61 interventional studies indexed under Otitis Media with Effusion.

Browse Otitis Media with Effusion studies →

Lead sponsor

Aghia Sophia Children's Hospital of Athens is the lead sponsor of 5 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
3 Years to 12 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • children operated for their adenoid hyperthrophy with an adenoid size of 3 (measured in a scale of 1-3 intraoperatively or from lateral neck x-ray) and otitis media with effusion causing an average air-bone gap of greater than 20db. Children should be otherwise healthy with an of I and between 3-12 years old of age

Exclusion criteria

Exclusion Criteria:

  • other health problems especially related with the condition eg cleft palate
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

05

Study design

Phase
Phase 2
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
52 participants (actual)

Study arms

  • Active comparator
    A-T

    Procedure: adenoidectomy, myringotomy, tubes insertion

  • Experimental
    A-M

    Procedure: A-M

Interventions

  • Procedureadenoidectomy, myringotomy, tubes insertion

    adenoidectomy, myringotomy and tubes insertion (A-T)against adenoidectomy and myringotomy alone (A-M)

  • ProcedureA-M

    adenoidectomy and myringotomy alone

06

What researchers measure

Primary outcomes

  1. OM-6

    Time frame: one year post operative

Secondary outcomes

  1. tympanogram type B

    Time frame: one year

07

Study locations

1 site
  • Department of Otolaryngology-Head and Neck Surgery, Aghia Sophia Children's Hospital of Athens
    Athens, Greece
08

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Sep 2007, a primary completion of May 2009 and a completion of May 2009. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 27, 2008
First posted
Mar 6, 2008
Start
Sep 2007
Primary completionActual
May 2009
CompletionActual
May 2009
Last update
Jan 23, 2012
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 23, 2012, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00629694
Lead sponsor
Aghia Sophia Children's Hospital of Athens
Responsible party
Ioannis Vlastos (MD, Aghia Sophia Children's Hospital of Athens) — Principal investigator
First posted
Mar 6, 2008
Start date
Sep 2007
Primary completion
May 2009
Completion
May 2009
Last update
Jan 23, 2012

Study contacts

Ioannis M Vlastos, MD
principal investigator · Aghia Sophia Children's Hospital of Athens
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2012. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion